Health Headlines for Tuesday, January 26

Agency head skips budget hearing and lawmakers pounce

Crain’s New York Business

The state Department of Financial Services, which regulates health insurance in New York, skipped a state budget hearing Monday—an absence lawmakers used to hammer the agency on recent shortcomings.

Read the full article

Cuomo’s placebo drug-price plans

New York Daily News

Americans and New Yorkers are by now familiar with the cycles of outrage over skyrocketing prescription drug prices, not the least of which was Martin Shkreli raising the price of a toxoplasmosis drug, Daraprim, by several thousand percent overnight.

Read the full article

New Yorkers have one week left to sign up for health insurance

Syracuse Post Standard

The New York health insurance exchange is reminding state residents Sunday is the deadline to enroll in health insurance for 2016.

Read the full article

Prescription price is less than cup of coffee

Democrat and Chronicle

Why did I pay $16.39 for a one-month supply of a generic formulation for a prescription last year and for the same prescription this year, I’ll pay 63 cents?

Read the full article

Vicodin Scripts Down After Tighter Controls

Med Page Today

Putting tighter regulations on hydrocodone combination products like Vicodin has flushed more than a billion pills from the market, federal researchers reported.

Read the full article

Diabetes Cure Hope After Cell Transplant Trial

Sky News

Scientists are hoping a cure for Type 1 diabetes is getting closer after they managed to halt the condition for six months in an experiment involving insulin-producing cells.

Read the full article

The Health Benefits of Knitting

New York Times/Blog

About 15 years ago, I was invited to join a knitting group. My reluctant response — “When would I do that?” — was rejoined with “Monday afternoons at 4,” at a friend’s home not three minutes’ walk from my own. I agreed to give it a try.

Read the full article

State to spend $200 million on drug-making facility in Dunkirk for Buffalo biotech firm

Buffalo News

The state plans to spend $200 million to build a high-tech drug-manufacturing center in Dunkirk for a Buffalo biotech firm that would create hundreds of jobs, The Buffalo News has learned.

Read the full article